On The Pen: The Weekly Dose

By Dave Knapp Man On The Mounjaro

What's On The Pen: The Weekly Dose about?

Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!

Download our free app to listen on your phone

On The Pen: The Weekly Dose episodes:

06.12.2024
Zepbound And Liver Disease
Send us a Text Message. Eli Lilly's phase 2 SYNERGY-NASH study shows tirzepatide effectively resolves MASH and improves fibrosis, offering hope for millions. Read more here: https://www.onthepen.com/post/tirzepatide-shows-promise-in-treating-mash-key-findings-from-the-synergy-nash-study Support the Show. MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Venmo:...
06.11.2024
On The Pen: The Weekly Dose 6.11.24
Send us a Text Message. Ro.co/supply-tracker FDA shortage update (tiktok video): Link:https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Tirzepatide%20Injection&st;=c EASL (European Association for the Study of the Liver) 2024 in Milan Italy Link: https://investor.lilly.com/news-releases/news-release-details/lillys-tirzepatide-was-superior-placebo-mash-resolution-and-more Link: https://www.biospace.com/article/mash-clash-between-lilly-and-boehringer-zealand-takes-center-stage-at-easl24/ Walgreen: Link: https://www.benefitspro.com/2024/06/03/walgreens-will-conduct-clinical-trials-for-boehringer-ingelheims-new-obesity-drug/?slreturn=20240610103336 Kroger (tiktok video): Link: https://www.aol.com/news/kroger-health-revamps-weight-management-132122808.html Eli Lilly Clinical trial: Link: https://clinicaltrials.gov/study/NCT06373146?term=tirzepatide&aggFilters;=status:act%20rec&rank;=6 Eli Lilly CFO: Link: https://www.prnewswire.com/news-releases/lilly-announces-departure-of-anat-ashkenazi-chief-financial-officer-302163882.html...
06.04.2024
On The Pen: The Weekly Dose 6.4.24
Send us a Text Message. https://ro.co/weight-loss/supply-tracker https://www.youtube.com/watch?v=mL_krAas70k Novo Nordisk Advertising:Novo Nordisk launches new advertising campaign "The Power of Wegovy"This advertisement includes the new indication for reduction of cardiovascular riskFor 2023, the #5 advertising spend for a drug was Rybelsus at $191 million. ...
05.31.2024
OTP EPS 68: Ro CEO Zach Reitano Talks GLP-1 Supply Tracker
Send us a Text Message. Zachariah Reitano is the founder of Ro, a telehealth company that has a vision of giving consumers more power over their health, he joins #OnThePen to talk all things #mounjaro #zepbound #wegovy #ozempic Reitano is the...
05.28.2024
On The Pen: The Weekly Dose 5.28.24
Send us a Text Message. On The Pen News: https://www.onthepen.com/blog SHOW NOTES: Ozempic study in New England Journal of Medicine: Link: https://www.bloomberg.com/news/articles/2024-05-24/novo-s-ozempic-slashes-risk-of-death-in-kidney-disease-study Compounding (tiktok video) Link: https://www.abc.net.au/news/2024-05-22/compound-pharmacies-banned-weight-loss-drugs-replica-ozempic/103861108 Zealand Pharma: Link: https://www.biospace.com/article/zealand-touts-phase-i-results-for-glp-1-glp-2-candidate-despite-modest-weight-loss-/ Inhaled GLP-1 medications Link: https://www.biostock.se/en/2024/05/iconovo-initiates-development-of-inhaled-obesity-treatment/ Oral version of tirzepatide (tiktok video): Link: https://ca.finance.yahoo.com/news/lexaria-awards-contract-third-glp-130500555.html Mounjaro approved for China (tiktok video): Link: https://www.bloomberg.com/news/articles/2024-05-21/china-clears-eli-lilly-s-weight-loss-drug-tirzepatide-only-for-diabetes Eli Lilly...
05.25.2024
On The Pen Live Eps 67: Survodutide Trial Participant Tells All!
Send us a Text Message. In this week’s episode of On The Pen Live, guest Scott Liberto of PlanetScott.com joins to discuss his experience in the Survodutide clinical trial. Survodutide is an investigational dual agonist targeting both the glucagon and GLP-1...
05.21.2024
On The Pen: The Weekly Dose 5.21.24
Send us a Text Message.
05.14.2024
On The Pen: The Weekly Dose 5.14.24
Send us a Text Message. MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Venmo: OnThePen Ca$h App: ManOnMounjaro Hello Fresh Free Box: https://www.hellofresh.com/pages/raf_lp11?c=FIH-XR3LF83PJ9QE&utm;_campaign=referralinvite&utm;_medium=clipboard&utm;_source=freebies&utm;_invitername=David&utm;_term=web&discount;_comm_id=992270dc-a684-4b10-bd34-da8bb5f811b2 SOCIAL LINKS https://www.tiktok.com/@manonthemounjaro https://twitter.com/ManOnMounjaro https://instagram.com/manonthemounjaro https://facebook.com/manonthemounjaro #Zepbound #releasethevials #mounjaro
05.11.2024
Threats to Lilly's Zepbound & Mounjaro Printing Press
Send us a Text Message. Roche Pharmaceuticals has acquired Carmot Therapeutics along with three obesity and type 2 diabetes candidates: CT-868 / CT-368 / CT-986 MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Venmo: OnThePen Ca$h App: ManOnMounjaro Hello Fresh Free Box: https://www.hellofresh.com/pages/raf_lp11?c=FIH-XR3LF83PJ9QE&utm;_campaign=referralinvite&utm;_medium=clipboard&utm;_source=freebies&utm;_invitername=David&utm;_term=web&discount;_comm_id=992270dc-a684-4b10-bd34-da8bb5f811b2 SOCIAL...
05.08.2024
On The Pen: The Weekly Dose 5.7.24
Send us a Text Message. MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Venmo: OnThePen Ca$h App: ManOnMounjaro SOCIAL LINKS https://www.tiktok.com/@manonthemounjaro https://twitter.com/ManOnMounjaro https://instagram.com/manonthemounjaro https://facebook.com/manonthemounjaro #Zepbound #Maritide #mounjaro LINKS Life Update Blog: Link: https://www.onthepen.com/post/i-m-tired-we-are-tired Wegovy released in Canada: Link: https://www.msn.com/en-ca/health/other/weight-loss-drug-wegovy-available-in-canada-starting-may-6/ar-AA1o1lZz Madison Muller at Bloomberg (friend of our community) had article "Why...
05.01.2024
Lilly Earnings Call: Zepbound and Mounjaro Updates
Send us a Text Message. Dave Knapp does a deep dive into todays Eli Lilly earnings call. https://www.onthepen.com/post/zepbound-vial-watch-eli-lilly-earnings-q1-2024 MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Venmo: OnThePen Ca$h App: ManOnMounjaro SOCIAL LINKS https://www.tiktok.com/@manonthemounjaro https://twitter.com/ManOnMounjaro https://instagram.com/manonthemounjaro https://facebook.com/manonthemounjaro Support the Show. MY WORK RELIES ON YOUR GENEROSITY, BECOME...
04.30.2024
On The Pen: The Weekly Dose 4/30/24
Send us a Text Message. 1.7 mg of Wegovy is no longer in shortage: Semaglutide: FDA website updated to show 1.7 mg of Wegovy is no longer in shortage Link: https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Semaglutide%20Injection&st;=c GNC introduces special section for GLP-1 users: GNC will have special section for...
04.23.2024
On The Pen: The Weekly Dose 4/23/24
Send us a Text Message. New obesity medicine company launches, Lilly expands manufacturing capacity with acquisition, and TikTok censors my content. Email Alerts: https://www.onthepen.com/emails BECOME A MEMBER HERE TO WATCH THE VIDEO: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join New Obesity Medicine Company Launches: https://metsera.com/news Lilly Acquires Nexus Facility: https://finance.yahoo.com/news/lilly-buy-injectable-drug-plant-175000782.html TikTok Mounjaro...
04.19.2024
Zepbound Vials: The Business Case
Send us a Text Message. Dave Knapp makes the business case for why Eli Lilly won’t simply release the vials - they have to. Email Alerts: https://www.onthepen.com/emails BECOME A MEMBER HERE TO WATCH THE VIDEO: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Bloomberg #ReleaseTheVials Feature: https://www.bloomberg.com/news/articles/2024-04-02/zepbound-shortage-patients-push-eli-lilly-to-release-more-obesity-drug-supply Yahoo Finanace #ReleaseTheVials Feature VIDEO: https://youtu.be/nQbYa47DF4Q?feature=shared #mounjaro...
04.15.2024
On The Pen: The Weekly Dose 4/16/24
Send us a Text Message. This week Dave Knapp covers GLP-1 censorship on TikTok, the rise of bootleg medication scrutiny, and just how big the GLP-1 market may get in 2024. Email Alerts: https://www.onthepen.com/emails BECOME A MEMBER HERE TO WATCH THE VIDEO: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Bloomberg...
04.13.2024
Sourcing Compound Tirzepatide
Send us a Text Message. 503a vs 503b pharmacies. What is the difference, and why you should care when it comes to compound tirzepatide and semaglutide. BECOME A MEMBER HERE TO WATCH THE VIDEO: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Get the whole story at: https://www.onthepen.com Bloomberg #ReleaseTheVials Feature: https://www.bloomberg.com/news/articles/2024-04-02/zepbound-shortage-patients-push-eli-lilly-to-release-more-obesity-drug-supply Yahoo...
04.09.2024
On The Pen: The Weekly Dose 4.9.24
Send us a Text Message. Get the whole story at: https://www.onthepen.com Bloomberg #ReleaseTheVials Feature: https://www.bloomberg.com/news/articles/2024-04-02/zepbound-shortage-patients-push-eli-lilly-to-release-more-obesity-drug-supply Yahoo Finanace #ReleaseTheVials Feature VIDEO: https://youtu.be/nQbYa47DF4Q?feature=shared Yahoo Finance Catalent / Novo Deal Resubmission: https://finance.yahoo.com/news/novo-nordisk-parent-refiles-us-103118874.html Bloomberg Lilly Germany Plant: https://www.bloomberg.com/news/articles/2024-04-08/lilly-s-2-5-billion-german-plant-will-boost-obesity-drug-supply Support the Show. MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER...
04.01.2024
Zepbound Single Dose Vials Approved!
Send us a Text Message. In the largest move since approving Tirzepatide for chronic weight management in November of 2023, the FDA has posted the approval of a single-dose vial presentation of Zepbound. With the complexity of manufacturing the current...
03.26.2024
On The Pen: The Weekly Dose 3/26/24
Send us a Text Message. All things VikingTide from Viking Therapeutics VK2735 https://ir.vikingtherapeutics.com/2024-03-26-Viking-Therapeutics-Announces-Results-from-Phase-1-Clinical-Trial-of-Oral-Tablet-Formulation-of-Dual-GLP-1-GIP-Receptor-Agonist-VK2735 Amazon Remedies (affiliate links pay a commission that supports the channel): Alcohol Wipes: https://amzn.to/49WH0Kr Ginger Chews: https://amzn.to/43l6crA Tums: https://amzn.to/3vlzo59 Peppermint Tea: https://amzn.to/3VjxT20
03.19.2024
On The Pen: The Weekly Dose 3/19/24
Send us a Text Message. Amazon Remedies (affiliate links pay a commission that supports the channel): Alcohol Wipes: https://amzn.to/49WH0Kr Ginger Chews: https://amzn.to/43l6crA Tums: https://amzn.to/3vlzo59 Peppermint Tea: https://amzn.to/3VjxT20
03.10.2024
Novo Nordisk Pipeline Obesity Medicines Announced
Send us a Text Message. Big news from Novo Nordisk and we have it all for you!! Cagrisema, high dose Semaglutide, new Amycretin, a triple angonist and more!
03.05.2024
On The Pen: The Weekly Dose 3/5/24
Send us a Text Message. This week Dave covers the latest in the Change Healthcare Hack, some interesting pubmed tirzepatide data , and Oprah’s exit from the Weight Watchers board of directors. Become a YouTube Community Member By Clicking Here: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join On The...
03.01.2024
Mounjaro to Zepbound and Beyond with Dr. Albert
Send us a Text Message. Dave Knapp (@ManOnTheMounjaro) joins Dr. Michael Albert, a leading voice in the obesity medicine, for a gripping conversation on the current and future state of obesity medicine. Become a Community Member By Clicking Here: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join On The Pen...
02.27.2024
On The Pen: The Weekly Dose 2/27/24
Send us a Text Message. This week we cover: - New readouts on the new Boehringer Ingleheim investigational med Survodutide. - Wegovy launches in Japan, and the - Change Healthcare cyber attack and how it’s effecting your prescription refills Become a Community Member...
02.20.2024
On The Pen: The Weekly Dose 2/20/24
Send us a Text Message. Become a Community Member By Clicking Here: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join On The Pen Live Show (All Episodes In Order): https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM For Those Facing GLP-1 Access Issues: Https://www.FlexFinance.Care Tell them “Dave sent you”
02.13.2024
Zepbound Mounjaro Ozempic News: 2.13.24
Send us a Text Message. Dive deep into the Novo Nordisk and Catalent merger and how that will affect the GLP-1 market.
02.07.2024
Q4 Eli Lilly Earnings Call Recap
Send us a Text Message. Man on the Mounjaro Dave Knapp recxaps the 2023 Q4 ELi Lilly Earnings Call as it relates to obesity medicine. Link To Earnings Call: https://investor.lilly.com/webcasts-and-presentations
02.06.2024
On The Pen: The Weekly Dose 2.6.24
Send us a Text Message.
02.01.2024
Q4 Novo Nordisk Earnings Call Recap
Send us a Text Message. In this special edition of the weekly dose podcast, Dave knapp covers the recent fourth-quarter earnings call from Novo Nordisk. What does this mean for users of Ozempic Wegovy?
01.30.2024
On The Pen: The Weekly Dose 1.30.24
Send us a Text Message.
01.23.2024
On The Pen: The Weekly Dose 1.23.24
Send us a Text Message. Weekly dose of Mounjaro Zepbound Wegovy Ozempic news!
01.16.2024
On The Pen: The Weekly Dose 1.16.24
Send us a Text Message. Popular Compound Pharmacy Closes: https://www.washingtonpost.com/business/2024/01/15/aca-pharmacy-weight-loss-drugs Ozempic Lawsuits https://nypost.com/2024/01/13/lifestyle/woman-suffers-life-threatening-bowel-injury-from-ozempic-suit/ FDA: Ozempic Doesn't Increase Suicide Risk https://news.yahoo.com/wegovy-ozempic-seem-less-dangerous-195000154.html Ozempic 1.7 back in stock https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-resumes-shipments-wegovy-17-mg-dose-us-2024-01-12/
01.14.2024
On The Pen: The Weekly Dose Podcast!
Send us a Text Message. Here's what to expect from The Weekly Dose Podcast from On The Pen! Support the Show. MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Venmo: OnThePen Ca$h App: ManOnMounjaro BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join SOCIAL LINKS https://www.tiktok.com/@manonthemounjaro https://twitter.com/ManOnMounjaro https://instagram.com/manonthemounjaro https://facebook.com/manonthemounjaro #Zepbound #releasethevials...

What's On The Pen: The Weekly Dose about?

Download our free app to listen on your phone

On The Pen: The Weekly Dose episodes:

Zepbound And Liver Disease

On The Pen: The Weekly Dose 6.11.24

On The Pen: The Weekly Dose 6.4.24

OTP EPS 68: Ro CEO Zach Reitano Talks GLP-1 Supply Tracker

On The Pen: The Weekly Dose 5.28.24

On The Pen Live Eps 67: Survodutide Trial Participant Tells All!

On The Pen: The Weekly Dose 5.21.24

On The Pen: The Weekly Dose 5.14.24

Threats to Lilly's Zepbound & Mounjaro Printing Press

On The Pen: The Weekly Dose 5.7.24

Lilly Earnings Call: Zepbound and Mounjaro Updates

On The Pen: The Weekly Dose 4/30/24

On The Pen: The Weekly Dose 4/23/24

Zepbound Vials: The Business Case

On The Pen: The Weekly Dose 4/16/24

Sourcing Compound Tirzepatide

On The Pen: The Weekly Dose 4.9.24

Zepbound Single Dose Vials Approved!

On The Pen: The Weekly Dose 3/26/24

On The Pen: The Weekly Dose 3/19/24

Novo Nordisk Pipeline Obesity Medicines Announced

On The Pen: The Weekly Dose 3/5/24

Mounjaro to Zepbound and Beyond with Dr. Albert

On The Pen: The Weekly Dose 2/27/24

On The Pen: The Weekly Dose 2/20/24

Zepbound Mounjaro Ozempic News: 2.13.24

Q4 Eli Lilly Earnings Call Recap

On The Pen: The Weekly Dose 2.6.24

Q4 Novo Nordisk Earnings Call Recap

On The Pen: The Weekly Dose 1.30.24

On The Pen: The Weekly Dose 1.23.24

On The Pen: The Weekly Dose 1.16.24

On The Pen: The Weekly Dose Podcast!

Other shows like On The Pen: The Weekly Dose: